A New Tool to Promote Patient's Engagement in Their Healthcare Process

Condition(s) studied

Investigational drug(s) / intervention(s)

Healthcare professionals: healthcare professionals (HCPs) targeted, including team members: we will involve 30 physicians (who are involved in the process of care towards patients with early breast cancer (10 oncologists, 10 breast surgeon, and 10 breast radiologists specifically) for the semi-structured interviews

Patients PDA group: Participants will receive via mail the final version of the PDA and a Qualtrics link with a battery of questionnaires

Patients control group: Participants will receive only the online link with the battery of questionnaires

Study summary

Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice.

Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.

Eligibility

Primary outcome measure(s)

• Development of an ad hoc Patient Decision Aid (PDA) — 3 months
  Patients in the Intervention group will receive via mail the final version of the PDA and a battery of questionnaires. Patients in the Control group will receive only the online link with the battery of questionnaires. In both the experimental and the control group, questionnaires will be administered one week after the first medical consultation (T0), one month later the first medical consultation (T1), and three months later the first medical consultations (T2). The difference between T1 and T0 and T2 and T0 will be calculated for each endpoint.

Trial sites (1)

More European Institute of Oncology trials in Italy

Other trials for the same condition